New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Multiple Factors Need to Be Addressed to Improve Late Mortality for Survivors of Childhood Cancer

Multiple Factors Need to Be Addressed to Improve Late Mortality for Survivors of Childhood Cancer

Matthew J. Ehrhardt, MD, MSIt is likely necessary to mitigate multiple factors that can affect health outcomes and may increase the risk of late mortality in survivors of childhood cancer, according t
World medicine November 09,2023
Multiple Factors Need to Be Addressed to Improve Late Mortality for Survivors of Childhood Cancer

Multiple Factors Need to Be Addressed to Improve Late Mortality for Survivors of Childhood Cancer

Matthew J. Ehrhardt, MD, MSIt is likely necessary to mitigate multiple factors that can affect health outcomes and may increase the risk of late mortality in survivors of childhood cancer, according t
World medicine November 09,2023
First-line Zolbetuximab Plus CAPOX Prolongs Survival in CLDN18.2+/HER2– Unresectable Locally Advanced or Metastatic Gastric/GEJ Adenocarcinoma

First-line Zolbetuximab Plus CAPOX Prolongs Survival in CLDN18.2+/HER2– Unresectable Locally Advanced or Metastatic Gastric/GEJ Adenocarcinoma

The addition of zolbetuximab (IMAB362) to CAPOX led to a statistically significant improvement in progression-free survival (PFS) and overall survival (OS) compared with placebo plus CAPOX as first-li
World medicine November 09,2023
First-line Zolbetuximab Plus CAPOX Prolongs Survival in CLDN18.2+/HER2– Unresectable Locally Advanced or Metastatic Gastric/GEJ Adenocarcinoma

First-line Zolbetuximab Plus CAPOX Prolongs Survival in CLDN18.2+/HER2– Unresectable Locally Advanced or Metastatic Gastric/GEJ Adenocarcinoma

The addition of zolbetuximab (IMAB362) to CAPOX led to a statistically significant improvement in progression-free survival (PFS) and overall survival (OS) compared with placebo plus CAPOX as first-li
World medicine November 09,2023
Elacestrant Highlights Promise of Oral SERDs in HR+/HER2– Metastatic Breast Cancer

Elacestrant Highlights Promise of Oral SERDs in HR+/HER2– Metastatic Breast Cancer

Antoinette R. Tan, MD, MHSTheFDA approval of the oral selective estrogen receptor degrader (SERD) elacestrant (Orserdu)underscores the potential for other oral SERDs currently under development,
World medicine November 09,2023
Elacestrant Highlights Promise of Oral SERDs in HR+/HER2– Metastatic Breast Cancer

Elacestrant Highlights Promise of Oral SERDs in HR+/HER2– Metastatic Breast Cancer

Antoinette R. Tan, MD, MHSTheFDA approval of the oral selective estrogen receptor degrader (SERD) elacestrant (Orserdu)underscores the potential for other oral SERDs currently under development,
World medicine November 09,2023
Renin Angiotensin Inhibitors Reduce Thrombotic Adverse Effects in Chronic Myeloproliferative Neoplasms

Renin Angiotensin Inhibitors Reduce Thrombotic Adverse Effects in Chronic Myeloproliferative Neoplasms

Patients with essential thrombocythemia and polycythemia vera (PV) who also had arterial hypertension experienced a higher cumulative incidence of thrombotic adverse effects (AEs) compared with those
World medicine November 09,2023
Renin Angiotensin Inhibitors Reduce Thrombotic Adverse Effects in Chronic Myeloproliferative Neoplasms

Renin Angiotensin Inhibitors Reduce Thrombotic Adverse Effects in Chronic Myeloproliferative Neoplasms

Patients with essential thrombocythemia and polycythemia vera (PV) who also had arterial hypertension experienced a higher cumulative incidence of thrombotic adverse effects (AEs) compared with those
World medicine November 09,2023
Neoadjuvant Inetetamab Combo Shows Efficacy, Tolerability in Locally Advanced HER2+ Breast Cancer

Neoadjuvant Inetetamab Combo Shows Efficacy, Tolerability in Locally Advanced HER2+ Breast Cancer

© stock.adobe.comThe combination of inetetamab (cipterbin), pertuzumab (Perjeta), paclitaxel, and carboplatin (TCbIP) administered elicited responses with an acceptable safety profile when administere
World medicine November 09,2023
Neoadjuvant Inetetamab Combo Shows Efficacy, Tolerability in Locally Advanced HER2+ Breast Cancer

Neoadjuvant Inetetamab Combo Shows Efficacy, Tolerability in Locally Advanced HER2+ Breast Cancer

© stock.adobe.comThe combination of inetetamab (cipterbin), pertuzumab (Perjeta), paclitaxel, and carboplatin (TCbIP) administered elicited responses with an acceptable safety profile when administere
World medicine November 09,2023
No overall cancer risk in people who donate stem cells

No overall cancer risk in people who donate stem cells

ReviewedDec 7 2010Results from four innovative studies help answer outstanding questions about stem cell transplant procedures in treating various hematologic malignancies. Research will be pres
World medicine November 09,2023
No overall cancer risk in people who donate stem cells

No overall cancer risk in people who donate stem cells

ReviewedDec 7 2010Results from four innovative studies help answer outstanding questions about stem cell transplant procedures in treating various hematologic malignancies. Research will be pres
World medicine November 09,2023
5 things you should know about stem cell research

5 things you should know about stem cell research

In just a few weeks, Michigan voters will have an important decision to make when casting their ballots.Not just who they want to be president, or to represent them in Congress, but what they want the
World medicine November 09,2023
5 things you should know about stem cell research

5 things you should know about stem cell research

In just a few weeks, Michigan voters will have an important decision to make when casting their ballots.Not just who they want to be president, or to represent them in Congress, but what they want the
World medicine November 09,2023
An advance toward using stem cells in 'regenerative medicine'

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.
World medicine November 09,2023
An advance toward using stem cells in 'regenerative medicine'

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.
World medicine November 09,2023
Cancer Genomics now available online

Cancer Genomics now available online

ReviewedFeb 2 2012Genome Research(www.genome.org) publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge
World medicine November 09,2023
Cancer Genomics now available online

Cancer Genomics now available online

ReviewedFeb 2 2012Genome Research(www.genome.org) publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge
World medicine November 09,2023
Hitting rewind on the spread of pancreatic cancer

Hitting rewind on the spread of pancreatic cancer

Interview conducted byDanielle Ellis, B.Sc.Jul 14 2022Thought LeadersLinxiang LanStaff ScientistThe Institute of Cancer ResearchIn this interview, News-Medical speaks to Linxiang Lan, a staff sc
World medicine November 09,2023
Hitting rewind on the spread of pancreatic cancer

Hitting rewind on the spread of pancreatic cancer

Interview conducted byDanielle Ellis, B.Sc.Jul 14 2022Thought LeadersLinxiang LanStaff ScientistThe Institute of Cancer ResearchIn this interview, News-Medical speaks to Linxiang Lan, a staff sc
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com